In-vivo Proliferative potential of primary human brain tumors; its correlation with histological classification and morphological features: II nonglial tumors

References

• Kernohan J W, Habon R F, Svien H J, Adson A W. A simplified classification of gliomas. Proc Staff Meet Mayo Clin 1949; 24: 71–5
   PubMed Web of Science ®Google Scholar
• Regingertz J. Grading of gliomas. Acta Pathol Microbiol Scand 1950; 27: 51–64
   PubMedGoogle Scholar
• Zulch K J. Histological typing of tumors of the central nervous system. International Histological Classification of Tumors. No. 21. WHO, Geneva 1979; 17–57
   Google Scholar
• Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer 1988; 62: 2152–65
   Google Scholar
• Kepes J J. Review of the WHO's new proposed classification of brain tumors. proceedings of the XIth International Congress of Neuropathology, Kyoto, September 2–8, 1990, 87–102
   Google Scholar
• Russell D S, Rubinstein L J. Pathology of the tumors of the nervous system 5th edn., D S Russell, L J Rubinstein. Edward Arnold, London 1989; 1–570
   Google Scholar
• Fukui M, Iwaki T, Sawa H, Inoue T, Takeshita I, Kitampura K. Proliferative activity of meningiomas as evaluated by bromode-oxyuridine uptake examination. Acta Neurochir (Wien) 1986; 81: 135–41
   PubMedGoogle Scholar
• Burger P C, Shibata T, Kleihues P. Proliferation markers for neoplasms of the nervous system. Advances in Immuno-histochemistry, R. A. Delellis. Raven Press, New York 1988; 301–16
   Google Scholar
• Hoshino T, Nagashima T, Murovic J A, Wilson C B, Davis R L. Proliferative potential of human meningiomas of the brain. A cell kinetics study with bromodeoxyuridine. Cancer 1986; 58: 1466–72
   PubMed Web of Science ®Google Scholar
• Cho K G, Hoshino T, Nagashima T, Murovic J A, Wilson C B. Prediction of tumor doubling time in recurrent meningiomas. Cell kinetics studies with bromodeoxyuridine labelling. J Neurosurg 1986; 65: 790–4
   Google Scholar
• Nagashima T, Murovic J A, Hoshino T, Wilson C B, DeArmond S J. The proliferative potential of human pituitary tumors in situ. J Neurosurg 1986; 64: 588–93
   PubMedGoogle Scholar
• Hoshino T, Kobayashi S, Townsend J J, Wilson C B. A cell kinetics study on medullo blastomas. Cancer 1985; 55: 1711–3
   PubMedGoogle Scholar
• Murovic J A, Nagashima T, Hoshino T, Edwards M SB, Davis R L. Pediatric central nervous system tumors: A cell kinetic study with bromodeoxyuridine. Neurosurg 1986; 19: 900–904
   PubMedGoogle Scholar
• Baak J PA, Oort J. A manual of morphometry in diagnostic pathology. Springer Verlag, Berlin 1983; 18–20
   Google Scholar
• Hsu S M, Raine L, Fanger H. A comparative study of the peroxidase antiperoxidase method and an avidin-biotin-complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 1981; 75: 734–8
   PubMed Web of Science ®Google Scholar
• Dinda A K, Sarkar C, Roy S. Rosenthal fibres: an immuno-histochemical ultrastructural and immuno-electron microscopic study. Acta Neuropathol (Berl) 1990; 79: 456–60
   PubMedGoogle Scholar
• Roy S, Sarkar C, Dinda A K. Pituitary adenomas: An ultrastructural, immunohistochemical and immunoelectronmicroscopic study. Neuropathology in Brain Research, F Ikuta. Excerpta Medica, Elsevier Scientific Publishers, Amsterdam 1991; 163–72
   Google Scholar
• Kepes J J. Presidential address: The histopathology of meningioma. A reflection of origin and expected behaviour. J Neuropathol Exp Neurol 1986; 45: 95–107
   PubMed Web of Science ®Google Scholar
• Skullerud K, Loken A C. The prognosis of meningiomas. Acta Neuropathol (Berl) 1974; 29: 337–44
   PubMed Web of Science ®Google Scholar
• Jellinger K, Slowik F. Histological subtypes and prognostic problems in meningiomas. J Neurol 1975; 208: 279–98
   PubMed Web of Science ®Google Scholar
• Adegbite A B, Chan M I, Paine K WE, Tan L K. The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 1983; 58: 51–6
   PubMed Web of Science ®Google Scholar
• Jaskelainen J. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 1986; 26: 461–9
   PubMedGoogle Scholar
• Roggendorf W, Schuster T, Peiffer J. Proliferative potential of meningiomas determined with monoclonal antibody ki-67. Acta Neuropathol (Berl) 1987; 73: 361–4
   PubMed Web of Science ®Google Scholar
• May P L, Broome J C, Lawry J, Buxton R A, Battersby R DE. The prediction of recurrence in meningiomas. A flow cytometric study on paraffin embedded archival material. J Neurosurg 1989; 71: 347–51
   Google Scholar
• Kopelson G, Hinggood R M, Kleinman G M. Medulloblastoma. The identification of prognostic subgroups and implications for multimodality management. Cancer 1983; 51: 312–19
   PubMedGoogle Scholar
• Caputy A J, McCullough D CC, Manz H J, Patterson K, Hammock M K. A review of the factors influencing the prognosis of medulloblastoma. The importance of cell differentiation. J Neurosurg 1987; 66: 80–7
   PubMedGoogle Scholar
• Packer R J, Sutton L N, Rorkee L B, Hitman P A, Sposto R, Rosen-stock J G, Bruce D A, Schut L. Prognostic importance of cellular differentiation in medullo blastoma of childhood. J Neurosurg 1984; 61: 296–301
   PubMed Web of Science ®Google Scholar
• Segmas J, Biczysko W, Gabryel P, Morkowski S. Medullo blastoma: histological evaluation and prognosis. A clinical immuno-histochemical and electron microscopic study. Child's Nerv Syst 1987; 3: 74–82
   PubMedGoogle Scholar
• Chatty E M, Earle K M. Medullo-blastoma. A report of 201 cases with emphasis on the relationship of histologic variants to survival. Cancer 1971; 28: 977–83
   PubMedGoogle Scholar
• Goldberg-Stern H, Gadoth N, Stern S, Copen I J, Zaizov R, Sandbank U. The prognostic significance of glial fibrillary acidic protein staining in medullo-blastoma. Cancer 1991; 68: 568–73
   PubMedGoogle Scholar
• Hoshino T, Nagashima T, Cho K G, Murovic J A, Hodes J E, Wilson C B, Edwards M SB, Pills L H. S-phase fraction of human brain tumors in situ measured by uptake of bromodeoxyuridine. Int J Cancer 1986; 38: 369–74
   PubMed Web of Science ®Google Scholar